• Explore /
  • Poster
  • / Outcomes of patients with metastatic clear cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors.

Outcomes of patients with metastatic clear cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors.

Abstract Poster

Authors

null

Amishi Yogesh Shah

The University of Texas MD Anderson Cancer Center, Houston, TX

Amishi Yogesh Shah , Ritesh Kotecha , Emily Lemke , Anuradha Chandramohan , Joshua Chaim , Pavlos Msaouel , Lianchun Xiao , Jianjun Gao , Matthew T Campbell , Amado J. Zurita , Jennifer Wang , Paul Gettys Corn , Eric Jonasch , Robert J. Motzer , Padmanee Sharma , Martin Henner Voss , Nizar M. Tannir

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer

Track

Renal Cell Cancer

Sub Track

Renal Cell Cancer

Citation

J Clin Oncol 37, 2019 (suppl 7S; abstr 575)

DOI

10.1200/JCO.2019.37.7_suppl.575

Abstract #

575

Poster Bd #

E14

Abstract Disclosures

Similar Posters

First Author: Amishi Yogesh Shah

First Author: Neil J. Shah

First Author: Meredith M. Regan

First Author: Audreylie Lemelin